# Roivant Sciences Ltd.: Form 4, filed Oct 20, 2021

- Company: [Roivant Sciences Ltd.](/companies/roiv.md) (CIK 1635088)
- Form: 4
- Filed: 2021-10-20
- Accepted by EDGAR: Oct 20, 2021, 17:14 ET
- Period: 2021-10-18
- Accession: 0000950103-21-016172
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1635088/000095010321016172/xslF345X03/dp160070_4-rsltd.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1635088/000095010321016172/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1635088/000095010321016172/xslF345X03/dp160070_4-rsltd.xml

Filed Oct 20, 2021.
Source: SEC EDGAR, the filing index for accession 0000950103-21-016172. Last ingested by Listed: Nov 3, 2026, 20:10 ET. No prices; not investment advice.